United States · FDA National Drug Code directory

Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 11822-0021_5b8e52d1-e70e-41ca-99ae-c9eb4a9687df
Product NDC: 11822-0021
Form: TABLET, EXTENDED RELEASE
Composition / generic term: Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride
Labeler: Rite Aid Corporation
Marketing category: ANDA
Marketing start / end (source format): 20220331
Source listing expiry: 20261231

Source-listed ingredients

FEXOFENADINE HYDROCHLORIDE — 60 mg/1
PSEUDOEPHEDRINE HYDROCHLORIDE — 120 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

4 BLISTER PACK in 1 CARTON (11822-0021-4) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 11822-0021-4
6 BLISTER PACK in 1 CARTON (11822-0021-6) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 11822-0021-6

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →